Skip to main content

Gland Pharma IPO likely to raise Rs 6,000-7,000 crore

The IPO comprises a fresh issue of up to Rs 1,250 crore and an offer for sale of up to 3,48,63,635 equity shares by promoters.

 

Hyderabad-based pharmaceutical company Gland Pharma has filed a draft red herring prospectus with capital market regulator Sebi for its proposed initial public offering on July 10.

The IPO comprises a fresh issue of up to Rs 1,250 crore and an offer for sale of up to 3,48,63,635 equity shares by promoters.

The offer for sale consists of 1,93,68,686 equity shares by Fosun Pharma Industrial Pte Ltd, 1,00,47,435 equity shares by Gland Celsus Bio Chemicals, up to 35,73,014 equity shares by Empower Discretionary Trust, and 18,74,500 equity shares by Nilay Discretionary Trust.

Gland Pharma has established a portfolio of products across various therapeutic segments such as anti-diabetic, anti-infectives, anti-malaria, anti-neoplastics, blood-related, cardiac, gastro-intestinal and hormones through a combination of delivery systems including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops.

Read full article - Click Here


Comments

Popular posts from this blog

US investors' rights law firm announces probe against HDFC Bank

  The investigation is reportedly resulting from allegations that HDFC Bank may have issued materially misleading business information to the investing public.   American Law firm, Rosen Law, has announced an investigation of potential securities claims on behalf of shareholders of HDFC Bank. The firm is also preparing for a class action suit on behalf of bank’s shareholders. The investigation is reportedly resulting from allegations that HDFC Bank may have issued materially misleading business information to the investing public. Rosen Law, on its website, asked investors to provide their details if they have purchased HDFC Bank Limited securities and would like to receive information about the investigation concerning the class action to recover the investor losses in HDFC Bank Limited securities. “A representative of The Rosen Law Firm will contact you at no cost to you and provide you detailed information concerning the proposed class action to rec...

At 156.6 Times, Burger King IPO Receives The Second Largest Subscription In 2020

The state-owned defence company, Mazagon Dock Shipbuilders' Rs 443-crore IPO had seen the highest subscription in 2020 at 157.4 times The initial public offering of Burger King, one of the fastest growing quick service restaurant chains in India with 268 outlets, turned out to be the third issue in the calendar year 2020 to cross the subscription mark of 150 times. With a subscription of 156.6 times, it has received the second highest subscription in the current year after Mazagon Dock Shipbuilders. Burger King India targets to open 700 restaurants by December 2026. The Rs 810-crore IPO was subscribed 156.6 times overall during December 2-4 as it received bids for 1,166 crore equity shares against offer size of 7.44 crore equity shares (excluding anchor book portion). The strong interest in the issue was owing to attractive valuations, strong brand positioning, healthy financial prospects, expected robust store expansion plans of the quick service restaurant industry in I...

IT stocks rally, TCS hits new high; Wipro, Infosys, HCL Tech gain 2-4% each

Wipro added over 4 percent after the IT firm said its Board will consider a buyback plan on October 13. L&T Infotech, Infosys, HCL Tech, Mphasis, Tech Mahindra and Mindtree were the other gainers. The Indian stock market is trading higher for the sixth day in a row with Sensex jumping 479.35 points or 1.2 percent at 40358.30, and the Nifty gaining 132.20 points or 1.13 percent at 11871.10. The market rally was largely aided by IT stocks with the index jumping almost 4 percent led by index heavyweight Tata Consultancy Services (TCS) which hit new high. The company reported a profit after tax of Rs 7,475 crore for the quarter ended September 2020, registering a 6.7 percent sequential growth. The board members of the company have approved a proposal to buy back up to 5,33,33,333 equity shares of company, being 1.42 percent of the total paid up equity share capital, at around Rs 3,000 per equity share for an aggregate amount up to Rs 16,000 crore. Research and broking firm ICIC...